Industry Outlook

The global blood typing, grouping and infectious disease screening market will reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. Blood grouping comprises ABO grouping and Rh tests, whereas nucleic acid testing (NAT) and immunoassays are preferred for blood screening to identify the presence of infectious agents. The major factors affecting the market growth include increasing blood donations and the growing awareness among blood donors, rising affordability of the advanced diagnostic tests such as NAT for blood screening, and increasing awareness towards the infection-free blood during donations. Furthermore, the growing cases of road accidents and trauma cases demand huge quantity of blood, which needs blood screening kits and consumables thereby accounting for market growth. Additionally, the growing cases of infections (particularly viral infections) raises demand for the diagnosis kits. According to the Centers for Disease Control and Prevention (CDC), in 2016, an approximate of 2,150 cases reported with West Nile Virus (WNV) infections in the United States. According to the HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary’s Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. Furthermore, around 60% of the United States population expected to be infected by cytomegalovirus (CMV) once before 40 years of age. Such high cases of the infections globally indicates huge demand for efficient and accurate diagnostic and blood screening kits thereby accounting to the market growth.

"Growing Demand for Blood and Blood Products to Support Dominance of ABO Grouping Segment"

In 2017, ABO grouping segment dominated the global blood typing, grouping and infectious disease screening market with over 45% market share, in terms of value. The dominance of the segment attributed to the growing demand for blood and blood products in the market. Furthermore, the rising cases of road accidents fuels the demand for ABO grouping segment. According to statistics presented by Insurance Institute for Highway Safety (IIHS), in 2016, an approximate of 34,439 fatal motor vehicle crashes were reported in the United States, which indicates high demand for blood thereby contributing to the segment growth. Additionally, Nucleic Acid Testing (NAT) segment identified to experience a lucrative growth with the fastest CAGR owing to the growth of infectious diseases.

"Consumables Segment Dominated the Global Market Through the Forecast Period"

In 2017, consumables segment dominated the global market and expected to witness the fastest growth during the forecast period from 2018 to 2026. Consumables are inevitably required to perform the tests in huge amounts, thus requirement of large volume plays a key role in dominance of the segment in global market. The currently available assay kits are easy to use and handle, delivering high precision results. Technological advancement in the diagnostic instruments further increases the accuracy of the tests subsequently driving the market.

"High Infection Rate of Cytomegalovirus (CMV) to Facilitate Market Position for Blood Screening Tests"

According to the CDC, at least 60% of the United States is exposed to the cytomegalovirus and 1 out of 3 women infected with CMV expected to pass this virus to unborn child. Additionally, on an average 150 infants are born with CMV infections each year in the United States. Such high infection cases of CMV account for high demand for diagnosis and contribute to the supremacy of the CMV segment. Furthermore, cases of other infections are also rising, which account for lucrative growth of the market during the forecast period from 2018 to 2026.

"Asia Pacific to Experience Lucrative Growth with Double Digit CAGR followed by Latin America during the Forecast Period"

The Asia Pacific expected to witness lucrative growth during the forecast period owing to high awareness of blood donations, growing road accidents and injuries in the region, and growing cases of infections. Additionally, the rising accessibility of diagnostic techniques and the penetration of the major players in developing countries of Asia Pacific and Latin America contribute to the double-digit growth of both the regional markets. In 2017, North America dominated the global market with over 34% of the market share, in terms of value. The prime reasons for the dominance of the region is high incidence of infectious diseases, costly treatment regimens compared to other parts of the world & availability of better diagnostic devices.

"Presence of Numerous Players have Fragmented the Global Market"

The global blood typing, grouping and infectious disease screening market is highly fragmented comprising numerous players. Several players in the market are involved in the manufacturing of kits and reagents used for ABO blood grouping and diagnosis of infectious diseases. Key players in the market include Abbot Laboratories, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Grifols S.A, Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd. and Thermo Fisher Scientific, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Blood Typing, Grouping and Infectious Disease Screening market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Blood Typing, Grouping and Infectious Disease Screening market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Blood Typing, Grouping and Infectious Disease Screening market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Blood Typing, Grouping and Infectious Disease Screening market?
• Which is the largest regional market for Blood Typing, Grouping and Infectious Disease Screening market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Blood Typing, Grouping and Infectious Disease Screening market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Blood Typing, Grouping and Infectious Disease Screening market worldwide?